Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
NCT ID:
NCT00322218
Pre Assignment Details:
Of the 151 screened patients 68 patients were assigned to treatment (Full analysis set, FAS). Three patients showed major protocol deviations and thus were excluded from the "per protocol set"(PPS). The PPS comprised 65 patients.
Recruitment Details:
Diffuse large B-cell lymphoma (DLBCL) Patients at the age of at least 60 years and in complete remission (CR or CRu) after 6 or 8 cycles of a first-line treatment with Cyclophosphamide Doxorubicin hydrochloride Vincristine Prednisolone- Rituximab (CHOP-R) were enrolled in the study.
Study:
NCT00322218
Study Brief:
Results Section:
NCT00322218